Immune modulatory mesenchymal stem cells derived from human embryonic stem cells through a trophoblast-like stage

Citations Over TimeTop 14% of 2015 papers

Abstract

Mesenchymal stem/stromal cells (MSCs) have great clinical potential in modulating inflammation and promoting tissue repair. Human embryonic stem cells (hESCs) have recently emerged as a potentially superior cell source for MSCs. However, the generation methods reported so far vary greatly in quality and efficiency. Here, we describe a novel method to rapidly and efficiently produce MSCs from hESCs via a trophoblast-like intermediate stage in approximately 11-16 days. We term these cells "T-MSCs" and show that T-MSCs express a phenotype and differentiation potential minimally required to define MSCs. T-MSCs exhibit potent immunomodulatory activity in vitro as they can remarkably inhibit proliferation of cocultured T and B lymphocytes. Unlike bone marrow MSCs, T-MSCs do not have increased expression of inflammatory mediators in response to IFNγ. Moreover, T-MSCs constitutively express a high level of the immune inhibitory ligand PD-L1 and elicit strong and durable efficacy in two distinct animal models of autoimmune disease, dextran sulfate sodium induced colitis, and experimental autoimmune encephalomyelitis, at doses near those approved for clinical trials. Together, we present a simple and fast derivation method to generate MSCs from hESCs, which possess potent immunomodulatory properties in vitro and in vivo and may serve as a novel and ideal candidate for MSC-based therapies.

Related Papers

• The Expression of SCL Gene in Bone Marrow Stromal Cells From Patients with Leukemia and Normal Individuals(2002)
• Study on Bone Marrow-derived Stromal Cells Enhancement of Hematopoiesis Reconstitution(2004)
• Observation on the biological behavior of acute leukemia bone marrow stroma cells(2005)
• Experimental study on the levels of IL-1α、IL-1β and IL-11 secreted by bone marrow stromal cells of patients with psoriasis(2009)
• Study of The Level of TNF-α,LIF and HGF Secreted by Bone Marrow Stromal Cells in Psoriatic Patients(2009)